Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation: A randomized, double-blind, controlled study

Annals of Internal Medicine

Volumn 116, Issue 10, 1992, Pages 821-828

  Ziegler, Thomas R ^a   Young, Lorraine S ^a   Benfell, Kathleen ^a   Scheltinga, Marc ^b   Hortos, Kari ^c   Bye, Rancy ^a   Morrow, Frank D ^d   Jacobs, Danny O ^a   Smith, Robert J ^a   Antin, Joseph H ^a   Wilmore, Douglas W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c Mt Clemens General Hospital   (United States)

^d TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; AMINO ACID COMPOSITION; AMINO ACID METABOLISM; AMMONIA BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; HEMATOLOGIC DISEASE; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; MALE; MORBIDITY; NITROGEN BALANCE; PARENTERAL NUTRITION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

ADULT; BONE MARROW TRANSPLANTATION; DOUBLE-BLIND METHOD; FEMALE; GLUTAMINE; HUMAN; MALE; MIDDLE AGE; NITROGEN; OPPORTUNISTIC INFECTIONS; PARENTERAL NUTRITION; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027102761     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-116-10-821     Document Type: Article

References (52)

1. Thomas ED, Clift RA, Storb R. Indications for bone marrow transplantation. Annu Rev Med. 1984;35:1-9.
2. Schmidt GM, Blume KG, Bross KJ, Spruce WE, Waldron JC, Levine R. Parenteral nutrition in bone marrow transplant recipients. Exp Hematol. 1980;8:506-11.
3. Szeluga DJ, Stuart RK, Brookmeyer R, Utermohlen V, Santos GW. Energy requirements of parenterally fed bone marrow transplant patients. JPEN J Parenter Enterai Nutr. 1985;9:139-43.
4. Cheney CL, Abson KG, Aker SN, Lenssen P, Cunningham BA, Buergel NS, et al. Body composition changes in marrow transplant recipients receiving total parenteral nutrition. Cancer. 1987;59: 1515-9.
5. Weisdorf S, Hofland C, Sharp HL, Teasley K, Schissel K, McGlave PB, et al. Total parenteral nutrition in bone marrow transplantation: a clinical evaluation. J Pediatr Gastroenterol Nutr. 1984;3:95-100.
6. McDonald GB, Shulman HM, Sullivan KM, Spencer GD. Intestinal and hepatic complications of human bone marrow transplantation. Parts I and II. Gastroenterology. 1986;90:460-84.
7. Meyers JD. Infections in marrow transplant recipients. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and Practice of Infectious Diseases. Third edition. New York: Churchill Livingstone; 1991:2291-4.
8. Wilmore DW. The Metabolic Management of the Critically Ill. Second edition. New York: Plenum Medical Book Company; 1980.
9. Scrimshaw NS, Taylor CE, Goodon JE. Interactions of nutrition and infection. Am J Med. Sci. 1973;237:367-403.
10. American College of Physicians. Parenteral nutrition in patients receiving cancer chemotherapy. Ann Intern Med. 1989;110:734-6.
11. Weisdorf SA, Lysne J, Wind D, Haake RJ, Sharp HL, Goldman A, et al. Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation. 1987;43:833-8.
12. Cheney CL, Lenssen P, Aker SN, Cunningham BA, Gauvreau JM, Darbinian J, et al. Sex differences in nitrogen balance following marrow grafting for leukemia. J Am Coll Nutr. 1987;6:223-30.
13. Lenssen P, Cheney CL, Aker SN, Cunningham BA, Darbinian J, Gauvreau JM, et al. Intravenous branched chain amino acid trial in marrow transplant recipients. JPEN J Parenter Enterai Nutr. 1987; 11:112-8.
14. Reed MD, Lazarus HM, Herzig RH, Halpin TC Jr, Gross S, Husak MP, et al. Cyclic parenteral nutrition during bone marrow transplantation in children. Cancer. 1983;51:1563-70.
15. Wilmore DW, Black PR, Muhlbacher F. Injured man: trauma and sepsis. In: Winters RW, ed. Nutritional Support of the Seriously Ill Patient. New York: Academic Press; 1983:33-52.
16. Welbourne TC. Interorgan glutamine flow in metabolic acidosis. Am J Physiol. 1987;253:F1069-76.
17. Windmueller HG. Glutamine utilization by the small intestine. Adv Enzymol. 1982;53:201-37.
18. Newsholme EA, Newsholme P, Curi R, Challoner E, Ardawi MS. A role for muscle in the immune system and its importance in surgery, trauma, sepsis and burns. Nutrition. 1988;4:261-8.
19. O'Dwyer ST, Scott T, Smith RJ, Wilmore DW. 5-Fluorouracil toxicity on small intestinal mucosa but not white blood cells is decreased by glutamine [Abstract]. Clin Res. 1987;35:369A.
20. Klimberg VS, Souba WW, Dolson DJ, Salloum RM, Hautamaki RD, Plomley DA, et al. Prophylactic glutamine protects the intestinal mucosa from radiation injury. Cancer. 1990;66:62-8.
21. Fox AD, Kripke SA, De Paula J, Berman JM, Settle RG, Rombeau JL. Effect of a glutamine-supplemented enterai diet on methotrexate-induced enterocolitis. JPEN J Parenter Enterai Nutr. 1988;12: 325-31.
22. Fox AD, Kripke SA, DePaula JA, Berman JM, Settle RG, Romberu JL. Glutamine-supplemented diets prolong survival and decrease mortality in experimental enterocolitis. JPEN J Parenter Enteral Nutr. 1987;12(Suppl):8S.
23. Stehle P, Zander J, Mertes N, Albers S, Puchstein CH, Lawin P, et al. Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lancet. 1989;1:231-3.
24. Hammarqvist F, Wernerman J, Ali R, von der Decken A, Vinnars E. Addition of glutamine to total parenteral nutrition after elective abdominal surgery spares free glutamine in muscle, counteracts the fall in muscle protein synthesis, and improves nitrogen balance. Ann Surg. 1989;209:455-61.
25. Ziegler TR, Benfell K, Smith RJ, Young LS, Brown E, Ferrari-Baliviera E, et al. Safety and metabolic effects of L-glutamine administration in humans. JPEN J Parenter Enterai Nutr. 1990; 14(Suppl):137S-46S.
26. Antin JH, Bierer BE, Smith BR, Ferrara J, Guinan EC, Sieff C, et al. Selective depletion of bone marrow T-lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies. Blood. 1991;78:2139-49.
27. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 1974;18:295-304.
28. Sjolin J, Stjernstrom H, Henneberg S, Hambraeus L, Friman G. Evaluation of urinary 3-methylhistidine excretion in infection by measurements of methylhistidine and creatinine ratios. Am J Clin Nutr. 1989;49:62-70.
29. Mondzac A, Ehrlich GE, Seegmiller JE. An enzymatic determination of ammonia in biological fluids. J Lab Clin Med. 1965;66:526-31.
30. Smith RJ, Panico KA. Automated analysis of o-phthalaldehyde derivatives of amino acids in physiological fluids by reverse phase high performance liquid chromatography. J Liq Chromatog. 1985;8: 1783-95.
31. Wassner SJ, Schlitzer JL, Li JB. A rapid sensitive method for the determination of 3-methylhistidine in urine and plasma using HPLC. Anal Biochem. 1980;104:284-9.
32. Szeluga DJ, Stuart RK, Brookmeyer R, Utermohlen V, Santos GW. Nutritional support in bone marrow transplant recipients: a prospective randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res. 1987;47:3309-16.
33. Streat SJ, Beddoe AH, Hill GL. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma. 1987;27:262-6.
34. Mulder PO, Bouman JG, Gietema JA, Van Rijsbergen H, Mulder NH, Van der Geest S, et al. Hyperalimentation in autologous bone marrow transplantation for solid tumors. Comparison of total parenteral nutrition versus partial parenteral plus enterai nutrition. Cancer. 1989;64:2045-52.
35. Sheldon GF, Peterson SR, Sanders R. Hepatic dysfunction during hyperalimentation. Arch Surg. 1978;113:504-8.
36. O'Dwyer ST, Smith RJ, Hwang TL, Wilmore DW. Maintenance of small bowel mucosa with glutamine enriched parenteral nutrition. JPEN J Parenter Enterai Nutr. 1989;13:579-85.
37. Jepson MM, Bates P, Broadbent P, Pell JM, Millward DJ. Relationship between glutamine concentration and protein synthesis in rat skeletal muscle. Am J Physiol. 1988;255:E166-72.
38. MacLennan PA, Smith K, Weryk B, Watt PW, Rennie MJ. Inhibitition of protein breakdown by glutamine in perfused rat skeletal muscle. FEBS Lett. 1988;237:133-6.
39. Walser M. Misinterpretation of nitrogen balances when glutamine stores fall or are replenished. Am J Clin Nutr. 1991;53:1337-8.
40. Pirsch JD, Maki DG. Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow. Ann Intern Med. 1986;104:619-31.
41. Meyers JD. Fungal infections in bone marrow transplant patients. Semin Oncol 1990;6(Suppl):10-3.
42. Sullivan KM, Kopecky KJ, Jocom J, Fisher L, Buckner CD, Meyers JD, et al. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med. 1990;323:705-12.
43. Kalkewitz D, Bendich A. Enzyme-induced asparagine and glutamine depletion and immune system function. Am J Clin Nutr. 1983;37: 1025-30.
44. Ardawi MS. Glutamine and glucose metabolism in human peripheral lymphocytes. Metabolism. 1988;37:99-103.
45. Parry-Billings M, Evans J, Calder PC, Newsholme EA. Does glutamine contribute to immunosuppression after major burns? Lancet. 1990;336:523-5.
46. Burke DJ, Alverdy JC, Aoys E, Moss GS. Glutamine-supplemented total parenteral nutrition improves gut immune function. Arch Surg. 1989;124:1396-9.
47. Hong RW, Helton WS, Rounds JD, Wilmore DW. Glutamine-supplemented TPN preserves hepatic glutathione and improves survival following chemotherapy. Surg Forum. 1990;16:9-11.
48. Petersen FB, Clift RA, Hickman RO, Sanders JE, Meyers JD, Kelleher J, et al. Hickman catheter complications in marrow transplant recipients. JPEN J Parenter Enterai Nutr. 1986;10:58-62.
49. Cohen ML, Murphy MT, Counts GW, Buckner CD, Clift RA, Meyen JD. Prediction by surveillance cultures of bacteremia among neutropenic patients treated in a protective environment. J Infect Dis. 1983;147:789-93.
50. Rabinowe SN, Freedman A, Demetri G, Soiffer R, Ritz J, Blake K, et al. Randomized double blind trial of rhGM-CSF in patients with B-cell non-Hodgkin's lymphoma (B-NHL) undergoing high dose chemoradiotherapy and monoclonal antibody purged autologous bone marrow transplantation (ABMT) [Abstract]. Blood. 1990; 76(Suppl 1):167a.
51. Nemunaitis J, Rabinowe SN, Singer JW, Bierman PJ, Vose JM, Freeman AS, et al. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med. 1991;324:1773-8.
52. Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med. 1991;325:164-70.